Rights granted for reproduction by any legitimate news organization (or blog, or syndicator). However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
Story Reads as of 2022-01-23 00:09:57: 2,618 views
REFERENCES: Biotechnology News, Rexin-G, Dr. Frederick L. Hall, Epeius, Biotech, Dr. Erlinda Maria Gordon, M.D., Clinical Research Unit, innovative anti-cancer agent, specialty pharmaceutical company, Orphan Drug Status by the FDA, New Genetic Medicine for Cancer research, Epeius Biotechnologies Corporation | ID:5923